Bliss GVS Pharma Limited — Others, 31-12-2024: Trading Window

Bliss GVS Pharma Limited has announced the closure of its trading window for insiders and designated individuals starting January 1, 2025, until 48 hours after the disclosure of the financial results for the quarter and nine months ending December 31, 2024. The date for the board meeting to discuss the financial results will be communicated later. This move indicates a standard compliance practice ahead of earnings announcements, aiming to prevent insider trading. Investors might see a neutral impact as this is a typical measure; however, existing uncertainty about the financial results could heighten short-term volatility.